Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people using tirzepatide report ear pain or discomfort during treatment, and it is understandably unsettling when a symptom seems unrelated to the medicine. Ear pain is not listed as a recognised side effect in the Mounjaro Summary of Product Characteristics, but that does not mean the link is imaginary — several plausible mechanisms can explain it, and knowing which one applies to you matters. Mounjaro (tirzepatide) is a prescription-only weight-management medicine, which means any new or persistent symptom should be discussed with the prescriber who oversees your treatment, not managed on guesswork alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's a few weeks into your first or second Mounjaro pen, nausea has been a regular guest, and now there's a dull ache sitting just behind your ear. Your first instinct is to wonder whether the medicine is to blame. It's a fair question, and the short answer is: possibly, but indirectly.
The most credible explanation clinicians offer is referred pain from the throat and jaw. GLP-1 and GIP receptor activity slows gastric emptying, and one of the most common results is persistent nausea, reflux, and repeated swallowing or retching. The muscles of the jaw and the soft tissues at the back of the throat share nerve pathways with the ear canal — specifically the auriculotemporal nerve and branches of the vagus nerve. When these tissues are under repeated strain, the brain can interpret the signal as ear pain even when the ear itself is entirely healthy. The NHS tirzepatide medicines page confirms nausea, vomiting and indigestion as common side effects, and the downstream effects of those GI symptoms can ripple in unexpected directions.
Jaw clenching is a related but distinct mechanism. People managing ongoing nausea often unconsciously tighten their jaw, particularly at night. The temporomandibular joint sits immediately in front of the ear canal, and even low-grade tension in that joint can produce a persistent ache that feels entirely like an ear problem. If your ear pain is worse in the morning or accompanied by jaw stiffness, this is worth raising with your GP or dentist as well as your prescriber.
There is a second, slower-developing explanation worth understanding. The Eustachian tube, which connects the middle ear to the back of the throat and regulates ear pressure, is sensitive to changes in body composition, posture, and the tissues surrounding the nasopharynx. As people lose weight (sometimes quickly in the early months of tirzepatide treatment) the soft tissue around the Eustachian tube can alter, temporarily affecting how well it opens and closes. The result is a sensation of fullness, muffled hearing, or an achy pressure that comes and goes.
This is not exclusive to Mounjaro. It has been documented in people losing weight through other means, including bariatric surgery. It tends to be self-limiting, settling as the body adjusts, but it can be genuinely uncomfortable in the interim. If you notice this more after swallowing, yawning, or changes in altitude (a long drive or a flight), Eustachian tube dysfunction is a plausible culprit.
Some patients also report that a blocked or congested nose (which can itself be a minor side effect of nausea-driven breathing changes) worsens ear pressure symptoms. Staying well hydrated helps; dehydration from GI side effects can thicken mucus and compound the problem. There is more on how referred and secondary pain patterns appear during Mounjaro treatment if you are noticing discomfort in more than one area.
Most ear pain that appears shortly after starting or increasing a Mounjaro dose, and that fades within a few days, is almost certainly a secondary effect of GI symptoms rather than a direct pharmacological action. But there are situations where you should not wait to see whether it passes.
Get medical help promptly if your ear pain is severe or getting worse rather than settling, if you notice discharge from the ear, sudden hearing loss or ringing, if you develop a fever alongside the pain, or if the pain is one-sided and came on suddenly without any obvious nausea trigger. These patterns suggest an ear infection or another condition that needs its own treatment, independent of your Mounjaro prescription.
Ear pain is also worth flagging to your prescriber if it is affecting your sleep or your daily comfort. A clinician can consider whether the dose titration schedule is contributing and whether any adjustment makes sense. This is one of the reasons aftercare from your prescribing team matters throughout treatment, not just at the consultation stage.
If you are trying to work out whether other physical symptoms you are experiencing are related to treatment, our guides on abdominal gas and Mounjaro, eye-related changes during tirzepatide, and wind and bloating on GLP-1 medicines cover similar territory with the same evidence-first approach. And if cost or access has been on your mind, the context around recent Mounjaro price changes in the UK is worth reading before you compare providers.
Any unexpected symptom during treatment with a prescription medicine can be reported to the MHRA via the Yellow Card scheme, this applies to patients as well as clinicians, and reports from real-world users are genuinely how the post-marketing safety picture develops. Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA actively collects reports to build its long-term safety data. Your experience is part of that record.
At a GPhC-registered pharmacy like nume, every repeat order is reviewed by a prescriber before it is dispensed. If you have noted new symptoms (including ear pain) in your aftercare check-in, a clinician reads that information. You are not leaving a note in a void. If you have questions between orders, our team is available seven days a week. The FAQs also cover many of the practical questions that come up between consultations.
If you are not yet on treatment and want to understand whether tirzepatide might be appropriate for you, starting a free consultation is the first step. A prescriber reviews your answers the same day, a real clinician, reading your details, making a considered decision.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.